Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-034386
Filing Date
2021-10-12
Accepted
2021-10-12 17:25:14
Documents
5
Effectiveness Date
2021-10-12

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10029405_s8.htm S-8 74355
2 EXHIBIT 5.1 brhc10029405_ex5-1.htm EX-5.1 8601
3 EXHIBIT 23.1 brhc10029405_ex23-1.htm EX-23.1 2258
4 EXHIBIT 23.2 brhc10029405_ex23-2.htm EX-23.2 1983
5 image00001.jpg GRAPHIC 2298
  Complete submission text file 0001140361-21-034386.txt   91812
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-260200 | Film No.: 211319441
SIC: 2834 Pharmaceutical Preparations